Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
Tien-Wei Yu, Hsien‐Yuan Lane, Chieh‐Hsin Lin
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8208-8208
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 70
Prescribing in Older People
David G. Le Couteur, Sarah N. Hilmer, Nicholas Glasgow, et al.
(2025), pp. 627-712
Closed Access | Times Cited: 62
Mathematical models on Alzheimer's disease and its treatment: A review
Mitali Maji, Subhas Khajanchi
Physics of Life Reviews (2025) Vol. 52, pp. 207-244
Closed Access | Times Cited: 3
Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease
Qianqian Wang, Linyan Duan, Xingfan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4351-4351
Open Access | Times Cited: 59
Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases
Faheem Hyder Pottoo, Abdallah Mohammad Ibrahim, Ali Alammar, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 408-408
Open Access | Times Cited: 49
Panax Ginseng in the treatment of Alzheimer's disease and vascular dementia
Zhiyong Wang, Zhen Zhang, Jiangang Liu, et al.
Journal of Ginseng Research (2023) Vol. 47, Iss. 4, pp. 506-514
Open Access | Times Cited: 35
Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer’s and Parkinson’s diseases
Elizabeth M. Rhea, Alice Babin, P. C. Thomas, et al.
Tissue Barriers (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 25
Dendrimers in Neurodegenerative Diseases
María Dolores Pérez‐Carrión, Inmaculada Posadas
Processes (2023) Vol. 11, Iss. 2, pp. 319-319
Open Access | Times Cited: 22
Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation
Samo Ribarič
Biomedicines (2023) Vol. 11, Iss. 2, pp. 355-355
Open Access | Times Cited: 22
Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
Lingyan Zheng, Sichen Wu, Haichao Jin, et al.
Phytomedicine (2023) Vol. 116, pp. 154890-154890
Closed Access | Times Cited: 22
Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches
Amirreza Gholami
Neuroscience Letters (2023) Vol. 817, pp. 137532-137532
Closed Access | Times Cited: 22
The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations
Nicholas Aderinto, Gbolahan Olatunji, Muili Abdulbasit, et al.
Medicine (2023) Vol. 102, Iss. 43, pp. e35557-e35557
Open Access | Times Cited: 22
Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products
Yalan Zhou, Siqi Peng, Huizhen Wang, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 468-468
Open Access | Times Cited: 11
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 11
CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice
Yuanyu Shen, Xiaolei Zhang, Si-qi Liu, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy
Yang Xu, YangQuan Chen, Jia‐xin Xing, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
Grant A. Krafft, Jasna Jerecı̀ć, Eric Siemers, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 28
Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives
Muhammad Ayaz, Osama F. Mosa, Asif Nawaz, et al.
Phytomedicine (2023) Vol. 124, pp. 155272-155272
Closed Access | Times Cited: 20
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha Shah, Kunal G. Maheshwari, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 8, pp. 3847-3884
Closed Access | Times Cited: 16
Panax notoginseng saponins prevent dementia and oxidative stress in brains of SAMP8 mice by enhancing mitophagy
Yingying Yang, Wenya Chen, Zhenmei Lin, et al.
BMC Complementary Medicine and Therapies (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation
Maksim I. Sulatsky, Olga V. Stepanenko, Olesya V. Stepanenko, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Insights into the Neuroprotective Potential of Epicatechin: Effects against Aβ-Induced Toxicity in Caenorhabditis elegans
Begoña Ayuda‐Durán, Lidia Garzón-García, Susana González‐Manzano, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 5
Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases
Araz Rahimi, Parsa Sameei, Sana Mousavi, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9416-9431
Closed Access | Times Cited: 5
Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer’s Disease
Siddharth Shah, Hadeel M. Mansour, Tania M. Aguilar, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2113-2113
Open Access | Times Cited: 5
Ellagic Acid: A Green Multi-Target Weapon That Reduces Oxidative Stress and Inflammation to Prevent and Improve the Condition of Alzheimer’s Disease
Silvana Alfei, Guendalina Zuccari
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 844-844
Open Access
Page 1 - Next Page

Scroll to top